Sildenafil ameliorates cognitive deficits and tau pathology in a senescence-accelerated mouse model

L Orejana, L Barros-Miñones, J Jordán, E Puerta… - Neurobiology of …, 2012 - Elsevier
Aging is associated with a deterioration of cognitive performance and with increased risk of
neurodegenerative disorders. In the present study we tested whether the specific …

Implication of JNK pathway on tau pathology and cognitive decline in a senescence-accelerated mouse model

L Orejana, L Barros-Miñones, N Aguirre… - Experimental gerontology, 2013 - Elsevier
The senescence accelerated mouse-prone 8 (SAMP8) strain of mice is an experimental
model of accelerated senescence that also shares several pathological features with …

Sildenafil restores cognitive function without affecting β‐amyloid burden in a mouse model of Alzheimer's disease

M Cuadrado‐Tejedor, I Hervias… - British journal of …, 2011 - Wiley Online Library
BACKGROUND AND PURPOSE Inhibitors of phosphodiesterase 5 (PDE5) affect signalling
pathways by elevating cGMP, which is a second messenger involved in processes of …

Effect of phosphodiesterase-5 inhibition on apoptosis and beta amyloid load in aged mice

D Puzzo, C Loreto, S Giunta, G Musumeci, G Frasca… - Neurobiology of …, 2014 - Elsevier
Age-related cognitive decline is accompanied by an increase of neuronal apoptosis and a
dysregulation of neuroplasticity-related molecules such as brain-derived neurotrophic factor …

Inhibition of phosphodiesterase-5 rescues age-related impairment of synaptic plasticity and memory

A Palmeri, L Privitera, S Giunta, C Loreto… - Behavioural brain …, 2013 - Elsevier
Aging is characterized by a progressive cognitive decline that leads to memory impairment.
Because the cyclic nucleotide cascade is essential for the integrity of synaptic function and …

Sildenafil for the treatment of Alzheimer's disease: A systematic review

O Sanders - Journal of Alzheimer's Disease Reports, 2020 - content.iospress.com
Nitric oxide/cyclic guanosine monophosphate (cGMP) signaling is compromised in
Alzheimer's disease (AD), and phosphodiesterase 5 (PDE5), which degrades cGMP, is …

Phosphodiesterase 7 inhibitor reduced cognitive impairment and pathological hallmarks in a mouse model of Alzheimer's disease

R Perez-Gonzalez, C Pascual, D Antequera… - Neurobiology of …, 2013 - Elsevier
Elevated levels of amyloid beta (Aβ) peptide, hyperphosphorylation of tau protein, and
inflammation are pathological hallmarks in Alzheimer's disease (AD). Phosphodiesterase 7 …

Propranolol restores cognitive deficits and improves amyloid and Tau pathologies in a senescence-accelerated mouse model

M Dobarro, L Orejana, N Aguirre, MJ Ramírez - Neuropharmacology, 2013 - Elsevier
Ageing is associated with a deterioration of cognitive performance and with increased risk of
neurodegenerative disorders. Hypertension is the most-prevalent modifiable risk factor for …

Early sirtuin 2 inhibition prevents age-related cognitive decline in a senescence-accelerated mouse model

T Diaz-Perdigon, FB Belloch, A Ricobaraza… - …, 2020 - nature.com
The senescence-accelerated mouse prone-8 (SAMP8) model has been considered as a
good model for aged-related cognitive decline and Alzheimer's disease (AD). Since …

Sildenafil treatment of vascular dementia in aged rats

P Venkat, M Chopp, A Zacharek, C Cui… - Neurochemistry …, 2019 - Elsevier
Background and purpose: In this study, we employed a multiple microinfarction (MMI) based
vascular dementia (VaD) model in aged rats and tested the therapeutic effects of Sildenafil …